Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure

Environmental Research

Volumn 132, Issue , 2014, Pages 62-69

  Barry, Vaughn ^a   Darrow, Lyndsey A ^a   Klein, Mitchel ^a   Winquist, Andrea ^a   Steenland, Kyle ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

BMI; C8; Obesity; Perfluorooctanoic acid; PFOA

Indexed keywords

PERFLUOROOCTANOIC ACID;

ADULT; ANNUAL VARIATION; CHILD HEALTH; HEALTH RISK; OBESITY; POLLUTION EXPOSURE; REGRESSION ANALYSIS; SERUM; SEX-RELATED DIFFERENCE;

ADULT; ADULTHOOD; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; COMMUNITY; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PLANT; PRIORITY JOURNAL; RESIDENTIAL AREA; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; UNDERWEIGHT; UNITED STATES;

CALIFORNIA; OHIO VALLEY [CALIFORNIA]; UNITED STATES;

BMI; C8; OBESITY; PERFLUOROOCTANOIC ACID; PFOA;

ADULT; BODY MASS INDEX; CAPRYLATES; FEMALE; FLUOROCARBONS; FOLLOW-UP STUDIES; HUMANS; MALE; OBESITY; RETROSPECTIVE STUDIES; WATER POLLUTANTS, CHEMICAL; WEST VIRGINIA; YOUNG ADULT;

EID: 84905718608     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.03.025     Document Type: Article

References (37)

1. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health. Perspect. 2007, 115(11):1670-1676.
2. Barker D.J. The developmental origins of adult disease. J. Am. Coll. Nutr. 2004, 23(Suppl 6):588S-595S.
3. C8 Health Project, 2012. C8 Health project website. Available: (accessed 05.07.2013). http://publichealth.hsc.wvu.edu/c8/.
4. Calafat A.M., Wong L.-Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115(11):1596-1602.
5. Darrow L.A., Stein C.R., Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the mid-Ohio valley, 2005-2010. Environ. Health Perspect. 2013, 121(10):1207-1213.
6. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish Nation Birth Cohort. Environ. Health Perspect. 2007, 115(11):1677-1682.
7. Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., Fletcher T., et al. The C8 health project: design, methods, and participants. Environ. Health Perspect. 2009, 117(12):1873-1882.
8. Fromme H., Mosch C., Morovitz M., Alba-Alejandre I., Boehmer S., Kiranoglu M., et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ. Sci. Technol. 2010, 44(18):7123-7129.
9. Halldorsson T.I., Rytter D., Haug L.S., Bech B.H., Danielsen I., Becher G., et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ. Health Perspect. 2012, 120(5):668-673.
10. Hanssen L., Röllin H., Odland J.Ø., Moe M.K., Sandanger T.M. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J. Environ Monit. 2010, 12(6):1355-1361.
11. Hines E.P., White S.S., Stanko J.P., Gibbs-Flournoy E.A., Lau C., Fenton S.E. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol. Cell Endocrinol. 2009, 304(1-2):97-105.
12. Kato K., Wong L., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008. Environ. Sci. Technol. 2011, 45(19):8037-8045.
13. Kim S.K., Lee K.T., Kang C.S., Tao L., Kannan K., Kim K.R., et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ. Pollut. 2011, 159(1):169-174.
14. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99(2):366-394.
15. Lynch J., Smith G.D. A life course approach to chronic disease epidemiology. Annu. Rev. Public Health 2005, 26:1-35.
16. Maisonet M., Terrell M.L., McGeehin M.A., Christensen K.Y., Holmes A., Calafat A.M., et al. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ. Health Perspect. 2012, 120(10):1432-1437.
17. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80(7):643-648.
18. Mondal D., Lopez-Espinosa M.J., Armstrong B., Stein C.R., Fletcher T. Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water. Environ. Health Perspect. 2012, 120(5):752-757.
19. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 2008, 108(1):56-62.
20. Nawaz H., Chan W., Abdulrahman M., Larson D., Katz D.L. Self-reported weight and height: implications for obesity research. Am. J. Prev. Med. 2001, 20(4):294-298.
21. Newbold R.R., Padilla-Banks E., Snyder R.J., Phillips T.M., Jefferson W.N. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod. Toxicol. 2007, 23(3):290-296.
22. Oken E., Gillman M.W. Fetal origins of obesity. Obes. Res. 2003, 11(4):496-506.
23. Olsen G.W., Burris J., Ehresman D., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perluorohexanesulfonate, and perefluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115(9):1298-1365.
24. Post G.B., Cohn P.D., Cooper K.R. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ. Res. 2012, 116:93-117.
25. Savitz D.A., Stein C.R., Bartell S.M., Elston B., Gong J., Shin H.M., et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 2012, 23(3):386-392.
26. Savitz D.A., Stein C.R., Elston B., Wellenius G.A., Bartell S.M., Shin H.M., et al. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth recrods in the mid-Ohio valley. Environ. Health Perspect. 2012, 120(8):1201-1207.
27. Seals R., Bartell S.M., Steenland K. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ. Health Perspect. 2011, 119(1):119-124.
28. Shin H.-M., Vieira V.M., Ryan P.B., Detwiler R., Sanders B., Steenland K., et al. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works facility in West Virginia. Environ. Sci. Technol. 2011, 45(4):1435-1442.
29. Shin H.-M., Vieira V.M., Ryan P.B., Steenland K., Bartell S.M. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 health project. Environ. Health Perspect. 2011, 119(12):1760-1765.
30. Shiely F., Hayes K., Perry I.J., Kelleher C.C. Height and weight bias: the influence of time. PLoS One 2013, 8(1):e54386.
31. Steenland K., Jin C., MacNeil J., Lally C., Ducatman A., Vieira V., et al. Predictors of PFOA levels in a community surrounding a chemical plant. Environ. Health Perspect. 2009, 117(7):1083-1088.
32. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ. Health Perspect. 2010, 118(8):1100-1108.
33. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am. J. Epidemiol. 2009, 170(7):837-846.
34. Te Velde S.J., Twisk J.W., Van Mechelen W., Kemper H.C. Birth weight, adult body composition, and subcutaneous fat distribution. Obes. Res. 2003, 11(2):202-208.
35. White S.S., Fenton S.E., Hines E.P. Endocrine disrupting properties of perfluorooctanoic acid. J. Steroid Biochem. Mol. Biol. 2011, 127(1-2):16-26.
36. Winquist A., Lally C., Shin H.-M., Steenland K. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Environ. Health Perspect. 2013, 121(8):893-899.
37. Zhao Y., Tan Y.S., Sz Haslam, Yang C. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of perpubertal mammary gland development in C57BI/6 mice. Toxicol. Sci. 2010, 115(1):214-224.